Evelo Biosciences, Inc.

OTCPK:EVLO Stok Raporu

Piyasa değeri: US$7.6k

Evelo Biosciences Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresino data
CEO sahipliğin/a
Yönetim ortalama görev süresi4.8yrs
Yönetim Kurulu ortalama görev süresiVeri yok

Son yönetim güncellemeleri

Recent updates

Is Evelo Biosciences (NASDAQ:EVLO) Using Debt In A Risky Way?

Aug 18
Is Evelo Biosciences (NASDAQ:EVLO) Using Debt In A Risky Way?

Evelo Biosciences GAAP EPS of -$0.40 beats by $0.03

Aug 11

Marella Thorell is the new finance chief of Evelo Biosciences

Jul 18

Evelo Biosciences: Hope After Dilution?

Jun 06

Evelo Biosciences (NASDAQ:EVLO) Has Debt But No Earnings; Should You Worry?

Mar 21
Evelo Biosciences (NASDAQ:EVLO) Has Debt But No Earnings; Should You Worry?

Is Evelo Biosciences (NASDAQ:EVLO) Weighed On By Its Debt Load?

Sep 25
Is Evelo Biosciences (NASDAQ:EVLO) Weighed On By Its Debt Load?

What Type Of Shareholders Make Up Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Share Registry?

Mar 11
What Type Of Shareholders Make Up Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Share Registry?

Evelo Bio secures ~$67.5M capital raise

Jan 29

Evelo Biosciences expands EDP1815 mid-stage trial to atopic dermatitis

Jan 07

Trade Alert: The Independent Chairman Of Evelo Biosciences, Inc. (NASDAQ:EVLO), David Epstein, Has Just Spent US$51k Buying 77% More Shares

Dec 15
Trade Alert: The Independent Chairman Of Evelo Biosciences, Inc. (NASDAQ:EVLO), David Epstein, Has Just Spent US$51k Buying 77% More Shares

Do Institutions Own Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares?

Dec 11
Do Institutions Own Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares?

Evelo Biosciences identifies new lead oncology candidate

Dec 09

Evelo Bio's EDP1815 completes enrollment targeting interim data in mid-stage psoriasis study

Dec 03

Evelo Biosciences EPS beats by $0.04

Oct 29

CEO

Evelo Biosciences CEO'su yok ya da onlar hakkında elimizde veri yok.


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Craig Jalbert
Presidentless than a yearVeri yokVeri yok
Chun Zhang
Chief Technical Operations & Quality Officer4.8yrsVeri yokVeri yok
Mark Bodmer
Chief Scientific Officer and President of Research & Development8.6yrsUS$1.15m0.14%
$ 10.3
Jessica Cotrone
VP & Head of Communicationsno dataVeri yokVeri yok
Leslie Wardwell-Scott
VP and Head of Corporate Development & Strategic Integration2.4yrsVeri yokVeri yok
Andrea Itano
Head of Research4.8yrsVeri yokVeri yok
Duncan McHale
Chief Medical Officer6.8yrsUS$1.23m0.089%
$ 6.8
Douglas Maslin
Senior Director & Immunology Clinical Leadno dataVeri yokVeri yok

4.8yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim: EVLO 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.8 yıldır).